| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.007 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.095 | 0.009 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.094 | 0.009 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |